Skip to main content
. 2024 Oct 30;11:1492358. doi: 10.3389/fnut.2024.1492358

Figure 4.

Figure 4

(A,B) The survival and recurrence comparison in hepatolithiasis-related intrahepatic cholangiocarcinoma (HICC) patients between the NLR. (C,D) The survival and recurrence comparison in non-hepatolithiasis-related intrahepatic cholangiocarcinoma (NHICC) patients between the NLR<2.36 group and the NLR≥2.36 group.